Alliancebernstein L.P. Sells 38,078 Shares of Tenet Healthcare Corporation $THC

Alliancebernstein L.P. trimmed its position in Tenet Healthcare Corporation (NYSE:THC) by 4.8% in the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 752,176 shares of the company’s stock after selling 38,078 shares during the period. Alliancebernstein L.P. owned approximately 0.86% of Tenet Healthcare worth $152,722,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other large investors have also made changes to their positions in the business. Boston Partners lifted its holdings in shares of Tenet Healthcare by 38.8% during the 3rd quarter. Boston Partners now owns 3,147,555 shares of the company’s stock valued at $638,958,000 after purchasing an additional 880,413 shares during the last quarter. Ameriprise Financial Inc. raised its stake in Tenet Healthcare by 8.0% in the second quarter. Ameriprise Financial Inc. now owns 2,119,423 shares of the company’s stock valued at $373,020,000 after buying an additional 157,109 shares during the last quarter. AQR Capital Management LLC boosted its holdings in Tenet Healthcare by 62.3% in the third quarter. AQR Capital Management LLC now owns 1,876,423 shares of the company’s stock worth $380,989,000 after acquiring an additional 720,160 shares in the last quarter. Norges Bank acquired a new position in shares of Tenet Healthcare during the second quarter valued at about $206,981,000. Finally, Raymond James Financial Inc. raised its position in shares of Tenet Healthcare by 47.1% in the 2nd quarter. Raymond James Financial Inc. now owns 671,202 shares of the company’s stock valued at $118,132,000 after purchasing an additional 214,871 shares during the last quarter. 95.44% of the stock is owned by institutional investors and hedge funds.

Analysts Set New Price Targets

Several analysts have weighed in on THC shares. Mizuho boosted their target price on shares of Tenet Healthcare from $235.00 to $265.00 and gave the stock an “outperform” rating in a research report on Thursday, March 12th. TD Cowen reiterated a “buy” rating on shares of Tenet Healthcare in a research note on Thursday, February 12th. Cantor Fitzgerald reissued an “overweight” rating on shares of Tenet Healthcare in a research report on Wednesday, March 4th. Wells Fargo & Company restated an “overweight” rating and issued a $265.00 target price on shares of Tenet Healthcare in a research note on Monday, February 16th. Finally, Morgan Stanley reiterated an “overweight” rating and set a $260.00 price target on shares of Tenet Healthcare in a research note on Thursday, February 12th. One research analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating and three have issued a Hold rating to the stock. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $250.56.

Insider Buying and Selling

In related news, EVP Paola M. Arbour sold 6,500 shares of Tenet Healthcare stock in a transaction that occurred on Wednesday, March 11th. The stock was sold at an average price of $238.43, for a total transaction of $1,549,795.00. Following the completion of the transaction, the executive vice president directly owned 29,291 shares in the company, valued at approximately $6,983,853.13. This trade represents a 18.16% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider R. Scott Ramsey sold 8,017 shares of the company’s stock in a transaction that occurred on Monday, March 2nd. The stock was sold at an average price of $232.70, for a total value of $1,865,555.90. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 46,517 shares of company stock valued at $10,943,111 over the last ninety days. Company insiders own 0.81% of the company’s stock.

Tenet Healthcare Trading Down 3.5%

Shares of Tenet Healthcare stock opened at $219.58 on Tuesday. The stock has a market cap of $19.09 billion, a PE ratio of 14.18, a price-to-earnings-growth ratio of 1.10 and a beta of 1.39. The firm has a fifty day moving average price of $213.71 and a 200 day moving average price of $204.56. Tenet Healthcare Corporation has a 1 year low of $109.82 and a 1 year high of $247.21. The company has a debt-to-equity ratio of 2.18, a current ratio of 1.76 and a quick ratio of 1.68.

Tenet Healthcare (NYSE:THC) last posted its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating the consensus estimate of $4.08 by $0.62. The company had revenue of $5.53 billion for the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a net margin of 6.60% and a return on equity of 26.33%. The firm’s revenue was up 8.9% on a year-over-year basis. During the same period in the prior year, the company earned $3.44 earnings per share. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Equities research analysts predict that Tenet Healthcare Corporation will post 12.24 earnings per share for the current year.

Tenet Healthcare Profile

Tenet Healthcare Corporation (NYSE: THC) is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet’s operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.